Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control

Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.Medscape Medical News

Source: Medscape Dermatology Headlines - March 11, 2024 Category: Dermatology Tags: Dermatology Source Type: news